Skip to Main Content

Author Details

Paola Bisignano
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
2010
23
15
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36993679Merlin<sup>S13</sup> phosphorylation controls meningioma Wnt signaling and magnetic resonance imaging features.Res Sq2023
35879364Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice.Nat Biotechnol2022
35614225Mitochondrial uncouplers induce proton leak by activating AAC and UCP1.Nature2022
34158358SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma.Clin Cancer Res2021
32614861A kinetic mechanism for enhanced selectivity of membrane transport.PLoS Comput Biol2020
30548443A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition.ChemMedChem2019
29279396Protonation state of glutamate 73 regulates the formation of a specific dimeric association of mVDAC1.Proc Natl Acad Sci U S A2018
30340023Cilia-Associated Oxysterols Activate Smoothened.Mol Cell2018
30532032Inhibitor binding mode and allosteric regulation of Na<sup>+</sup>-glucose symporters.Nat Commun2018
29717135Substrate-bound outward-open structure of a Na<sup>+</sup>-coupled sialic acid symporter reveals a new Na<sup>+</sup> site.Nat Commun2018
29507231Conformational transitions of the sodium-dependent sugar transporter, vSGLT.Proc Natl Acad Sci U S A2018
26696252Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors.J Med Chem2016
26663255Development and Application of a Virtual Screening Protocol for the Identification of Multitarget Fragments.ChemMedChem2016
27325773Stochastic steps in secondary active sugar transport.Proc Natl Acad Sci U S A2016
27245612Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake.Sci Signal2016
25504761Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3β inhibitors.Angew Chem Int Ed Engl2015
26347990Ligand-Based Discovery of a New Scaffold for Allosteric Modulation of the μ-Opioid Receptor.J Chem Inf Model2015
24444037Kinetic characterization of fragment binding in AmpC β-lactamase by high-throughput molecular simulations.J Chem Inf Model2014
25073009Mechanistic insights into the allosteric modulation of opioid receptors by sodium ions.Biochemistry2014
23196990PLI: a web-based tool for the comparison of protein-ligand interactions observed on PDB structures.Bioinformatics2013
23198830In silico deconstruction of ATP-competitive inhibitors of glycogen synthase kinase-3β.J Chem Inf Model2012
21936510SERAPhiC: a benchmark for in silico fragment-based drug design.J Chem Inf Model2011
19781595Molecular dynamics analysis of the wild type and dF508 mutant structures of the human CFTR-nucleotide binding domain 1.Biochimie2010
  • 1 - 23 of 23

Recommended Authors

University of California san francisco
Career Start Year 2015
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 2015
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 2006
Number of shared co-authors 0
ShanghaiTech University, China iHuman Institute
Career Start Year 2006
Number of shared co-authors 2
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 1
Istituto di Scienze e Tecnologie Chimiche "Giulio Natta" - SCITEC CNR
Career Start Year 2005
Number of shared co-authors 1
Uppsala University
Career Start Year 2004
Number of shared co-authors 0
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Career Start Year 2003
Number of shared co-authors 1
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Inc. 16 Dekalb Pike
Career Start Year 2002
Number of shared co-authors 0
University of California
Career Start Year 2001
Number of shared co-authors 0
Monash University
Career Start Year 2000
Number of shared co-authors 1
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 0
INSERM
Career Start Year 1998
Number of shared co-authors 0
Oncology R&D
Career Start Year 1997
Number of shared co-authors 0
Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg
Career Start Year 1996
Number of shared co-authors 0
University of New Mexico School of Medicine
Career Start Year 1995
Number of shared co-authors 0
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Career Start Year 1994
Number of shared co-authors 1
Expert Systems Inc.
Career Start Year 1993
Number of shared co-authors 0
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1993
Number of shared co-authors 1
Lilly Research Laboratories
Career Start Year 1990
Number of shared co-authors 0
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1989
Number of shared co-authors 7
Center for Molecular Biology (ZMBH), Heidelberg University
Career Start Year 1989
Number of shared co-authors 0
Leiden Academic Centre for Drug Research (LACDR), Leiden University
Career Start Year 1988
Number of shared co-authors 0
Institut fur Pharmazeutische Chemie, Philipps-Universitat Marburg
Career Start Year 1988
Number of shared co-authors 0
Boston University
Career Start Year 1987
Number of shared co-authors 0
Department of Pharmaceutical Sciences, University of Perugia
Career Start Year 1986
Number of shared co-authors 0
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 0
Lilly Research Laboratories
Career Start Year 1977
Number of shared co-authors 1
Vanderbilt University
Career Start Year 1954
Number of shared co-authors 0

Collaborators

Co-authored papers 4
University of California san francisco
Co-authored papers 2
Co-authored papers 1
Cardiovascular Research Institute
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Co-authored papers 1
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
Gladstone Institutes, University of California san francisco
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Feinberg School of Medicine, Northwestern University
Co-authored papers 1
University of California San Francisco.
Co-authored papers 1
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
University of California San Francisco.
Co-authored papers 1
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
J. David Gladstone Institutes
Co-authored papers 1
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
University of California San Francisco.
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Co-authored papers 1
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
University of California berkeley
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Co-authored papers 1
Whitehead Institute for Biomedical Research
Co-authored papers 1
University of California San Francisco.
Co-authored papers 1
Co-authored papers 1